Efficacy of sofosbuvir plus ledipasvir versus sofosbuvir plus simeprevir in patients with acute hepatitis C

Trial Profile

Efficacy of sofosbuvir plus ledipasvir versus sofosbuvir plus simeprevir in patients with acute hepatitis C

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2016

At a glance

  • Drugs Ledipasvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms SLAM C
  • Most Recent Events

    • 17 Apr 2016 Efficacy results (n=29) presented at The International Liver Congress 2016.
    • 29 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top